Centauri Therapeutics Limited, an immunotherapy company with a proprietary platform technology applicable across a wide range of therapeutic indications, has appointed Dr. Debra Barker as Chief Medical Officer (CMO). An experienced clinical immunologist with broad executive experience across both big pharma and biotech, Barker joins Centauri’s leadership team to advance therapeutic development pipelines and ensure the smooth progression of the Company’s lead candidate through Phase I clinical...